Antibody levels following booster SARS-CoV-2 vaccination among dialysis patients initially vaccinated with adenovirus vector-based vaccine.

Willetts, Joanna; Ficociello, Linda H; Johnson, Curtis D; Alexander, Sandra E; Mullon, Claudy; Hymes, Jeffrey L

Willetts, Joanna; Ficociello, Linda H; Johnson, Curtis D; Alexander, Sandra E; Mullon, Claudy; Hymes, Jeffrey L.

Willetts J; Global Medical Office, Fresenius Medical Care, Waltham, MA, USA.
Ficociello LH; Global Medical Office, Fresenius Medical Care, Waltham, MA, USA.
Johnson CD; Spectra Laboratories, Southaven, MS, USA.
Alexander SE; Global Medical Office, Fresenius Medical Care, Waltham, MA, USA.
Mullon C; Global Medical Office, Fresenius Medical Care, Waltham, MA, USA.
Hymes JL; Global Medical Office, Fresenius Medical Care, Waltham, MA, USA. jeffrey.hymesmd@fmc-na.com.

J Nephrol ; 36(3): 609-611, 2023 04.

Article in English | MEDLINE | ID: covidwho-2209610

Subject(s)

Adenovirus Vaccines; COVID-19; Vaccines; Humans; Adenoviridae; COVID-19 Vaccines; SARS-CoV-2; Renal Dialysis; Vaccination

Keywords

Ad26.COV2.S; Antibody; COVID-19; Dialysis; Vaccination; mRNA vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Adenovirus Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2023 Document Type: Article Affiliation country: S40620-022-01559-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google